E Jason Abel

University Of Wisconsin-Madison

$1,089,951

Attributed

$2,333,076

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY2013–17

$2M$1.5M$1M$500K$0

'13

'14

'15

'16

'17

Funding mix

By agency

NIH$2,333,076 · 2

By mechanism

R33$1,491,750 · 1

K08$841,326 · 1

Top collaborators

Most similar at University Of Wisconsin-Madison

Same institution · by research overlap

Eszter Boros$5,033,742
Robert Jeraj$3,339,057
Douglas G McNeel$9,457,366
Joshua Michael Lang$8,279,603
Wei Huang$1,241,403

Others in their field

Top investigators on “Cancer Center”

Leonard Freedman · Leidos Biomedical Research, Inc.$885,275,552
David Heimbrook · Leidos Biomedical Research, Inc.$793,360,762
Larry Arthur$473,862,081
Richard A Gibbs · Baylor College Of Medicine$257,275,004
Lynn Briscoe · Leidos Biomedical Research, Inc.$248,567,868
Norman Wolmark · Nsabp Foundation, Inc.$237,419,252

Research focus

Cancer CenterIn VitroSamplingWisconsinCellsIn VivoMalignant NeoplasmsRenal Cell CarcinomaUniversitiesBaseDiagnosisSuccessRenal CarcinomaPathologicEnvironmentAccountingFellowshipBasic ScienceAngiogenesisFutureCancer ControlDesignCollaborationsDevelopment Plans

Grant awards (6)

Area C: Functional microscale organotypic assays to predict patient response to anti-angiogenesis therapies$1,491,750

R33 · FY2017 · CA

Role of NFxB/HIF2a axis in renal cell carcinoma progression$175,163

K08 · FY2017 · CA · contact PI

Role of NFxB/HIF2a axis in renal cell carcinoma progression$175,163

K08 · FY2016 · CA · contact PI

Role of NFxB/HIF2a axis in renal cell carcinoma progression$175,163

K08 · FY2015 · CA · contact PI

Role of NFxB/HIF2a axis in renal cell carcinoma progression$140,674

K08 · FY2014 · CA · contact PI

Role of NFxB/HIF2a axis in renal cell carcinoma progression$175,163

K08 · FY2013 · CA · contact PI